Dabur India Limited · NSE:DABUR
Dabur India — Q3 FY22 Earnings Presentation
25 slides from Dabur India's earnings presentation, Feb 2, 2022
Slide 1: Investor Communication cover letter to exchanges
^»SA^- ^^gl. ^'s^t^- Ref: SEC/SE/2021-22 ^ur India Ltd. Date:February 02, 2022 Scrip Symbol: NSE- DABUR, BSE Scrip Code: 500096 To, Corporate Relation Department National Stock Exchange of India Ltd BSE Ltd Exchange Plaza, 5th Floor Phiroze Jeejeebhoy Towers Plot No. C/l, G Block Bandra - Kurla Comp
Slide 2: Q3 FY22 Results Presentation
Building Business Purposefully And Sustainably Q3 FY22 RESULTS PRESENTATION 2ND FEBRUARY 2022 02-Feb-2022 1
Slide 3: Agenda
AGENDA 1 2 3 Q3 FY22 : 9M FY22: Q3 FY22: BUSINESS PERFORMANCE PERFORMANCE HIGHLIGHTS SUMMARY SUMMARY 02-Feb-2022 Q3 FY22 - Results Presentation 2
Slide 4: Agenda: Q3 FY22 Performance Summary
AGENDA 1 2 3 Q3 FY22 : 9M FY22: Q3 FY22: BUSINESS PERFORMANCE PERFORMANCE HIGHLIGHTS SUMMARY SUMMARY 02-Feb-2022 Q3 FY22 - Results Presentation 3
Slide 5: Q3 FY22 Performance Summary
Revenue from Operations EBITDA PBT PAT 2-yr CAGR: 11.8% 2-yr CAGR: 12.8% 2-yr CAGR: 16.1% 2-yr CAGR: 12.5% Q3 FY22 | PERFORMANCE SUMMARY 7.8% 9.3% 10.0% 2.3% 21.3% 22.1% 18.0% 20.9% 21.0% 21.7% 2,942 2,729 2,353 627 650 17.1% 574 20.5% 591 16.9% 493 492 503 482 398 Q3 FY20 Q3 FY21 Q3 FY22 Q3 FY20 Q3
Slide 6: Domestic FMCG Growth by Verticals
Q3 FY21 Sales Contribution Q3 FY22 Sales Contribution Q3 FY22 | DOMESTIC FMCG GROWTH – BY VERTICALS Food & Food & Beverage Beverage 10.9% 14.1% Healthcare Healthcare 40.0% 44.0% HPC 45.1% HPC 45.9% Healthcare Home & Personal Care (HPC) Food & Beverage (F&B) 2-yr CAGR: 11.4% 2-yr CAGR: 12.1% 2-yr CAG
Slide 7: International Business Performance
Q3 FY21 Sales Contribution Q3 FY22 Sales Contribution Others Q3 FY22 | INTENRATIONAL BUSINESS PERFORMANCE Others 2.2% 3.0% International International 25.3% 25.1% Domestic Domestic 72.5% 71.9% International Business grew by 8.7% in CC terms (6.7% in INR) Q3 FY22 Constant Currency Growth % 19.4% 17.3
Slide 8: Agenda: Business Highlights
AGENDA 1 2 3 Q3 FY22 : 9M FY22: Q3 FY22: BUSINESS PERFORMANCE PERFORMANCE HIGHLIGHTS SUMMARY SUMMARY 02-Feb-2022 Q3 FY22 - Results Presentation 7
Slide 9: Business Highlights - Healthcare
Health Supplements Digestives OTC & Ethicals Q3 FY22 | BUSINESS HIGHLIGHTS - HEALTHCARE Growth % (8.3%) 12.2% 3.6% 2-year CAGR 11.2% 5.8% 15.4% • Dabur Chyawanprash and Dabur • The portfolio continued to see • Driven by strong growth in Honey reported muted growths on strong momentum on the back Hon
Slide 10: Innovation - Healthcare
Q3 FY22 | INNOVATION - HEALTHCARE 9
Slide 11: Innovation - Healthcare: Introduced in Q3
Q3 FY22 | INNOVATION - HEALTHCARE Introduced in Q3 10
Slide 12: Innovation - Healthcare: Introduced in Q3
Q3 FY22 | INNOVATION - HEALTHCARE Introduced in Q3 11
Slide 13: Innovation - Healthcare: Introduced in Q3
Q3 FY22 | INNOVATION - HEALTHCARE Introduced in Q3 12
Slide 14: Business Highlights - HPC
Oral Care Hair Oils Shampoo Home Care Skin & Salon Growth % 6.7% 6.1% 21.2% 18.6% 3.2% Q3 FY22 | BUSINESS HIGHLIGHTS - HPC 2-year CAGR 16.9% 8.8% 24.1% 8.3% 6.1% • Toothpaste category • While category is • Shampoos portfolio • Robust double-digit • Excluding Sanitize recorded 8.1% seeing volume cont
Slide 15: Business Highlights - Food & Beverage
Beverages Foods Q3 FY22 | BUSINESS HIGHLIGHTS – FOOD & BEVERAGE Growth % 38.6% 26.4% 2-year CAGR 20.0% 21.1% • Beverage business continued to exhibit strong • Hommade brand continued to perform well driven by innovation momentum and portfolio expansion • In-home and out-of-home portfolios registered
Slide 16: Innovation - Food & Beverage
Q3 FY22 | INNOVATION – FOOD & BEVERAGE 15
Slide 17: International Business Innovation
MENA Q3 FY22 | INTERNATIONAL BUSINESS INNOVATION Herbolene Coconut Dermoviva Anti-bacterial NPDs in Healthcare Petroleum Jelly Handwash Range (Neem & Turmeric) Turkey UK SSA Long & Lasting Naturals Hobby Conditioner Range Vatika Multivitamin Hair Oil Leave-In Conditioner Mousse 16
Slide 18: Agenda: 9M FY22 Performance Summary
AGENDA 1 2 3 Q3 FY22 : 9M FY22: Q3 FY22: BUSINESS PERFORMANCE PERFORMANCE HIGHLIGHTS SUMMARY SUMMARY 02-Feb-2022 Q3 FY22 - Results Presentation 17
Slide 19: 9M FY22 Performance Summary
Revenue from Operations EBITDA PBT PAT 2-yr CAGR: 10.6% 2-yr CAGR: 11.8% 2-yr CAGR: 16.4% 2-yr CAGR: 11.4% 9M FY22 | PERFORMANCE SUMMARY 15.9% 15.4% 17.1% 9.8% 22.2% 22.4% 8,371 21.6% 21.5% 18.2% 7,225 21.1% 17.3% 6,838 17.0% 1,800 20.3% 1,879 1,560 1,604 1,445 1,440 1,315 1,387 1,164 9M FY20 9M FY2
Slide 20: 9M FY22 Domestic FMCG Growth by Verticals
9M FY21 Sales Contribution 9M FY22 Sales Contribution 9M FY22 | DOMESTIC FMCG GROWTH – BY VERTICALS Food & Food & Beverage Beverage 12.5% 16.4% Healthcare Healthcare 36.6% 40.6% HPC HPC 46.9% 47.0% Healthcare Home & Personal Care (HPC) Food & Beverage (F&B) 2-yr CAGR: 18.6% 2-yr CAGR: 9.7% 2-yr CAGR
Slide 21: 9M FY22 International Business Performance
9M FY21 Sales Contribution 9M FY22 Sales Contribution Others 9M FY22 | INTENRATIONAL BUSINESS PERFORMANCE Others 2.2% 2.1% International International 25.8% 25.5% Domestic Domestic 72.0% 72.4% International Business grew by 17.5% in CC terms (14.3% in INR) 9M FY22 Constant Currency Growth % 36.2% 24
Slide 22: Profit & Loss Statements
PROFIT & LOSS STATEMENTS
Slide 23: Consolidated P&L
All figures are in INR cr Q3 FY22 Q3 FY21 Y-o-Y (%) 9M FY22 9M FY21 Y-o-Y (%) Revenue from operations 2,941.8 2,728.8 7.8% 8,370.9 7,224.9 15.9% Other Income 96.7 80.9 19.5% 294.0 240.3 22.4% Total Income 3,038.5 2,809.8 8.1% 8,664.9 7,465.2 16.1% Material Cost 1,519.6 1,353.7 12.3% 4,316.4 3,591.2
Slide 24: Standalone P&L
All figures are in INR cr Q3 FY22 Q3 FY21 Y-o-Y (%) 9M FY22 9M FY21 Y-o-Y (%) Revenue from operations 2,224.4 2,071.1 7.4% 6,327.2 5,462.9 15.8% Other Income 81.1 68.1 19.1% 249.4 206.1 21.0% Total Income 2,305.5 2,139.2 7.8% 6,576.5 5,669.0 16.0% Material Cost 1,184.1 1,061.9 11.5% 3,357.9 2,772.3
Slide 25: For more information and updates, visit dabur.com
For more information and updates, visit: http://www.dabur.com /in/en-us/investor